
Industrializing Cell and Gene Therapy: The Economics of Multiply Labs' $75M Robotic Cleanroom Clusters
Dr. Dereck Mush, MD, MBAAstraZeneca is a biopharmaceutical company based in Cambridge, England, that develops medicines for cancer, rare diseases, and chronic conditions.
AstraZeneca was formed in 1999 when Sweden's Astra AB merged with Britain's Zeneca Group. Its work is organized around oncology, rare diseases, and a biopharmaceuticals unit that covers cardiovascular, renal, and metabolic disease as well as respiratory and immune conditions. The rare disease business grew out of Alexion, which AstraZeneca acquired in 2021 and which also added immunology expertise. The company discovers, tests, manufactures, and sells prescription medicines, working with health systems, payers, and prescribing physicians around the world.
Leadership as of 14 November 2026.
Executive Director and CEO

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBAMentions AstraZeneca
Related companies
Your daily HealthTech Signal
Get the latest HealthTech news, understand why it matters, and see where the industry is headed.



Read by teams at companies like: